Leading science, pioneering therapies

CRM Publications

Found 6 results
Filters: Keyword is Cell Line, Transformed  [Clear All Filters]
2013
Ding Y, Hubert CG, Herman J, Corrin P, Toledo CM, Skutt-Kakaria K, Vazquez J, Basom R, Zhang B, Risler JK et al..  2013.  Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells.Cancer Discov. 3(2):198-211.
Medine C.N, Lucendo-Villarin B, Storck C, Wang F, Szkolnicka D, Khan F, Pernagallo S, Black JR, Marriage HM, Ross JA et al..  2013.  Developing high-fidelity hepatotoxicity models from pluripotent stem cells.Stem Cells Transl Med. 2(7):505-9.
Porlan E, Morante-Redolat JManuel, M Marqués-Torrejón Á, Andreu-Agulló C, Carneiro C, Gómez-Ibarlucea E, Soto A, Vidal A, Ferrón SR, Fariñas I.  2013.  Transcriptional repression of Bmp2 by p21(Waf1/Cip1) links quiescence to neural stem cell maintenance.Nat Neurosci. 16(11):1567-75.
2010
Afshari FT, Kwok JC, Andrews MR, Blits B, Martin KR, Faissner A, ffrench-Constant C, Fawcett JW.  2010.  Integrin activation or alpha 9 expression allows retinal pigmented epithelial cell adhesion on Bruch's membrane in wet age-related macular degeneration.Brain. 133(Pt 2):448-64.
1998
Rambukkana A, Yamada H, Zanazzi G, Mathus T, Salzer JL, Yurchenco PD, Campbell KP, Fischetti VA.  1998.  Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae.Science. 282(5396):2076-9.
1996
Zeiger MA, Takiyama Y, Bishop JO, Ellison AR, Saji M, Levine MA.  1996.  Adenoviral infection of thyroid cells: a rationale for gene therapy for metastatic thyroid carcinoma.Surgery. 120(6):921-5.